Pazopanib Hydrochloride

ATC L01XE11 · 3 markets · 13 records

Pazopanib Hydrochloride 3 markets · 13 records Forms

AU 8 records · 4 strengths

  • 433.4 mgtabletPAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottlePAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle、VOTRIENT pazopanib 400 mg tablet bottle unknown
  • 216.7 mgtabletPAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottlePAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle、VOTRIENT pazopanib 400 mg tablet bottle unknown
  • 433 mgtabletPAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle unknown
  • 216.5 mgtabletPAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle unknown

SG 4 records · 2 strengths

  • 200 mgtabletPAZOPANIB-TEVA FC TABLETS 200 MGTYROKA FILM-COATED TABLETS 200 MG、VOTRIENT
  • 400 mgtabletVOTRIENT

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 VOTRIENT

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.